These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 10051123

  • 1. Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.
    Smith AJ, McKernan RM.
    Br J Pharmacol; 1999 Jan; 126(1):79-86. PubMed ID: 10051123
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C, Lazzeri G, Colucci R, Carignani D, Tognetti M, Baschiera F, Del Tacca M.
    Eur J Pharmacol; 1999 May 28; 373(1):71-84. PubMed ID: 10408253
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gastrin and CCK activate phospholipase C and stimulate pepsinogen release by interacting with two distinct receptors.
    Qian JM, Rowley WH, Jensen RT.
    Am J Physiol; 1993 Apr 28; 264(4 Pt 1):G718-27. PubMed ID: 8476056
    [Abstract] [Full Text] [Related]

  • 6. CCK-B receptor-mediated stimulation of polyphosphoinositide turnover in GH3 pituitary cells in response to cholecystokinin and pentagastrin.
    Smith AJ, Freedman SB.
    Life Sci; 1996 Apr 28; 58(11):883-95. PubMed ID: 8786694
    [Abstract] [Full Text] [Related]

  • 7. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 28; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 8. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 28; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

  • 9. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
    Ohlsson B, Fredäng N, Axelson J.
    Scand J Gastroenterol; 1999 Dec 28; 34(12):1224-9. PubMed ID: 10636070
    [Abstract] [Full Text] [Related]

  • 10. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors.
    Singh P, Owlia A, Espeijo R, Dai B.
    J Biol Chem; 1995 Apr 14; 270(15):8429-38. PubMed ID: 7721737
    [Abstract] [Full Text] [Related]

  • 11. Paracrine stimulation of cell growth by cholecystokinin/gastrin through cholecystokinin-B receptor on GH3 cells in vitro.
    Xu Y, Kaji H, Okimura Y, Matsui T, Abe H, Chihara K.
    Neuroendocrinology; 1996 Oct 14; 64(4):280-5. PubMed ID: 8895857
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
    Meyer G, Beinborn M, Sewing KF.
    Pharmacology; 1996 Jul 14; 53(1):48-59. PubMed ID: 8875601
    [Abstract] [Full Text] [Related]

  • 14. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert JM, Keane P, Labie C, Molimard JC, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh MP, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1999 May 14; 289(2):742-51. PubMed ID: 10215648
    [Abstract] [Full Text] [Related]

  • 15. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.
    Blackmore M, Hirst BH.
    Br J Cancer; 1992 Jul 14; 66(1):32-8. PubMed ID: 1637673
    [Abstract] [Full Text] [Related]

  • 16. Distinct receptors for cholecystokinin and gastrin on canine fundic D-cells.
    DelValle J, Chiba T, Park J, Yamada T.
    Am J Physiol; 1993 May 14; 264(5 Pt 1):G811-5. PubMed ID: 8098910
    [Abstract] [Full Text] [Related]

  • 17. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1995 Jan 14; 114(2):339-48. PubMed ID: 7881733
    [Abstract] [Full Text] [Related]

  • 18. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
    Saita Y, Yazawa H, Honma Y, Nishida A, Miyata K, Honda K.
    Eur J Pharmacol; 1994 Oct 14; 269(2):249-54. PubMed ID: 7851501
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cholecystokinin and gastrin peptides stimulate ODC activity in a rat pancreatic cell line.
    Scemama JL, De Vries L, Pradayrol L, Seva C, Tronchere H, Vaysse N.
    Am J Physiol; 1989 May 14; 256(5 Pt 1):G846-50. PubMed ID: 2719109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.